The anti-interleukin-1 in type 1 diabetes action trial - background and rationale (vol 25, pg 321, 2009)

被引:0
|
作者
Pickersgill, Linda M. S.
Mandrup-Poulsen, Thomas R.
机构
关键词
D O I
10.1002/dmrr.1051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:780 / 780
页数:1
相关论文
共 50 条
  • [1] The anti-interleukin-1 in type 1 diabetes action trial - background and rationale
    Pickersgill, Linda M. S.
    Mandrup-Poulsen, Thomas R.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (04) : 321 - 324
  • [2] Serum Signature Analysis of Participants of the Anti-Interleukin-1 in Diabetes Action (AIDA) Trial
    Hessner, Martin
    Kaldunski, Mary
    Jia, Shuang
    Wang, Xujing
    Cheong, Sami
    Pickersgill, Linda
    De Koning, Eelco
    Ziegler, Anette-G
    Boehm, Bernhard
    Badenhoop, Klaus
    Schloot, Nanette
    Bak, Jens Friis
    Pozzilli, Paolo
    Mauricio, Didac
    Donath, Marc
    Castano, Luis
    Wagner, Ana
    Lervang, Hans Henrik
    Perrild, Hans
    Mandrup-Poulsen, Thomas
    DIABETES, 2013, 62 : A63 - A64
  • [3] Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes
    Sumpter, Kathryn M.
    Adhikari, Soumya
    Grishman, Ellen K.
    White, Perrin C.
    PEDIATRIC DIABETES, 2011, 12 (07) : 656 - 667
  • [4] Anti-interleukin-1 therapy has mild hypoglycaemic effect in type 2 diabetes
    Huang, Jinya
    Yang, Yehong
    Hu, Renming
    Chen, Lili
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 1024 - 1028
  • [5] Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents (vol 22, pg 4, 2020)
    Biondi-Zoccai, Giuseppe
    Garmendia, Cristian M.
    Abbate, Antonio
    Giordano, Arturo
    Frati, Giacomo
    Sciarretta, Sebastiano
    Antonazzo, Barbara
    Versaci, Francesco
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (01)
  • [6] Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial
    Ruscitti, Piero
    Masedu, Francesco
    Alvaro, Saverio
    Airo, Paolo
    Battafarano, Norma
    Cantarini, Luca
    Cantatore, Francesco Paolo
    Canino, Giorgio
    D'Abrosca, Virginia
    Frassi, Micol
    Frediani, Bruno
    Iacone, Daniela
    Liakouli, Vasiliki
    Maggio, Roberta
    Mule, Rita
    Pentane, Ilenia
    Prevete, Immacolata
    Sinigaglia, Luigi
    Valenti, Marco
    Viapiana, Ombretta
    Cipriani, Paola
    Giacomelli, Roberto
    PLOS MEDICINE, 2019, 16 (09)
  • [7] Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: A surface ''receptor'' with anti-interleukin-1 function
    Re, F
    Sironi, M
    Muzio, M
    Matteucci, C
    Introna, M
    Orlando, S
    PentonRol, G
    Dower, SK
    Sims, JE
    Colotta, F
    Mantovani, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04): : 1841 - 1850
  • [8] A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
    Fleischmann, Roy M.
    Bliddal, Henning
    Blanco, Francisco J.
    Schnitzer, Thomas J.
    Peterfy, Charles
    Chen, Su
    Wang, Li
    Feng, Sheng
    Conaghan, Philip G.
    Berenbaum, Francis
    Pelletier, Jean-Pierre
    Martel-Pelletier, Johanne
    Vaeterlein, Ole
    Kaeley, Gurjit S.
    Liu, Wei
    Kosloski, Matthew P.
    Levy, Gwen
    Zhang, Lanju
    Medema, Jeroen K.
    Levesque, Marc C.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (07) : 1056 - 1069
  • [9] Mechanisms of action of immune globulin. (vol 157, pg 1, 2009)
    Fernandez-Cruz, E.
    Alecsandru, D.
    Sanchez Ramon, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 157 (03): : 446 - 446
  • [10] Association between type 1 and type 2 diabetes with periodontal disease and tooth loss (vol 36, pg 765, 2009)
    Kaur, Gaganpreet
    Holtfreter, Birte
    Rathmann, Wolfgang
    Schwahn, Christian
    Wallaschofski, Henry
    Schipf, Sabine
    Nauck, Matthias
    Voelzke, Henry
    Kocher, Thomas
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2009, 36 (12) : 1075 - 1075